Methyl aminolevulinate topical Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with methyl aminolevulinate topical
E
- E S P (erythromycin / sulfisoxazole)
- EC-Naprosyn (naproxen)
- Eczema Cream (coal tar topical)
- Edarbyclor (azilsartan medoxomil / chlorthalidone)
- Edecrin (ethacrynic acid)
- Elta Tar (coal tar topical)
- Elyxyb (celecoxib)
- Emtet-500 (tetracycline)
- enalapril / hydrochlorothiazide
- Enduron (methyclothiazide)
- Enduronyl (deserpidine / methyclothiazide)
- Enduronyl Forte (deserpidine / methyclothiazide)
- enoxacin
- Epiduo (adapalene / benzoyl peroxide topical)
- Epiduo Forte (adapalene / benzoyl peroxide topical)
- eprosartan / hydrochlorothiazide
- eravacycline
- Erbitux (cetuximab)
- erlotinib
- erythromycin / sulfisoxazole
- Eryzole (erythromycin / sulfisoxazole)
- Esbriet (pirfenidone)
- Esidrix (hydrochlorothiazide)
- Esimil (guanethidine / hydrochlorothiazide)
- esomeprazole / naproxen
- Estar (coal tar topical)
- ethacrynic acid
- Ethoxia (niacinamide / tazarotene topical)
- Etrafon (amitriptyline / perphenazine)
- Etrafon Forte (amitriptyline / perphenazine)
- etretinate
- Exforge HCT (amlodipine / hydrochlorothiazide / valsartan)
- Exna (benzthiazide)
- Exorex (coal tar topical)
- Exorex Penetrating Emulsion Psoriasis Medication (coal tar topical)
- Ezide (hydrochlorothiazide)
More about methyl aminolevulinate topical
- methyl aminolevulinate topical consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: topical photochemotherapeutics
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.